Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Mesoblast Limited
FDA Grants Rare Pediatric Disease Designation for Revascor
Business
Jan 19 2024
3 min read

FDA Grants Rare Pediatric Disease Designation for Revascor

news images

Mesoblast Ltd has released a press release.

View Attachment